A cross-sectional study assessing the safety profile of the mRNA-1273 vaccine across cancer patients and its relationship to patients' demographics
Latest Information Update: 15 Jul 2022
At a glance
- Drugs Elasomeran (Primary)
- Indications COVID 2019 infections
- Focus Adverse reactions
Most Recent Events
- 15 Jul 2022 New trial record
- 07 Jun 2022 Results presented at the 58th Annual Meeting of the American Society of Clinical Oncology